Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Astrocytoma × Evoked Potentials × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Recurrence 1 Glioblastoma 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Temozolomide 3 Radiotherapy 3 Amplified Fragment Length Polymorphism Analysis 3 Surveys and Questionnaires 2 Blood Specimen Collection 2 fluarix 1 X-Rays 1 Trail Making Test 1 Tetanus Toxoid 1 Radiation 1 Proton Magnetic Resonance Spectroscopy 1 Polymerase Chain Reaction 1 Pharmacogenomic Testing 1 Neuropsychological Tests 1 Magnetic Resonance Spectroscopy 1 Magnetic Resonance Imaging 1 Influenza Vaccines 1 In Situ Hybridization, Fluorescence 1 Immunohistochemistry 1 Hepatitis A Vaccines 1 Gene Rearrangement 1 FluLaval 1 FluBlok 1 Flow Cytometry 1 Evoked Potentials 1 Dynamic Contrast Enhanced Magnetic Resonance Imaging 1 Comparative Genomic Hybridization 1 Anthropogenic Effects 1 4-(4-dihexadecylaminostyryl)-N-methylpyridium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06273176 2024-02-22

RECMAP

Erasmus Medical Center

Astrocytoma, Brain Neoplasms, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡